CFP
AMAG

Cornerstone Financial Partners’s AMAG Pharmaceuticals AMAG Stock Holding History

Cornerstone Financial Partners’s Portfolio AMAG Stock Details AMAG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q2 		– Sell
-49,492
Closed -$1.12M – 152
2017
Q1 		$1.12M Buy
49,492
+37,312
+306% +$893K 0.37% 63
2016
Q4 		$421K Buy
+12,180
New +$364K 0.13% 110

Other funds holding AMAG

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
CCM
Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

Cornerstone Financial Partners's AMAG Position: Q2 2017 in Review

Cornerstone Financial Partners sold out of AMAG Pharmaceuticals (AMAG) in Q2 2017, closing a stake of 49,492 shares — an estimated $1.12M sold.

Cornerstone Financial Partners first reported a position in AMAG in Q4 2016 and held it in 2 quarters. The position peaked at $1.12M in Q1 2017. 174 funds tracked by Wall St. Rank hold AMAG as of Q2 2017.

  • Cornerstone Financial Partners reported no remaining AMAG Pharmaceuticals position as of Q2 2017 after selling out during the quarter.
  • Cornerstone Financial Partners sold 49,492 AMAG Pharmaceuticals shares in Q2 2017, an estimated $1.12M.
  • Cornerstone Financial Partners first reported a position in AMAG Pharmaceuticals in Q4 2016 and held it in 2 quarters.
  • Cornerstone Financial Partners's AMAG Pharmaceuticals position peaked at $1.12M in Q1 2017.
  • 174 funds tracked by Wall St. Rank held AMAG Pharmaceuticals as of Q2 2017.

Based on Cornerstone Financial Partners's 13F filing for Q2 2017, filed 21 Jul 2017.